Sickle cell vaso-occlusion: The dialectic between red cells and white cells

Autor(es)

Conran, Nicola ^[1] ; Embury, Stephen H. ^[2]

Afiliação do(s) autor(es)

^[1] Univ Campinas UNICAMP, Hematol Ctr, Barao Geraldo 13083-8, Campinas, SP - Brazil

^[2] Vanguard Therapeut Inc, Half Moon Bay, CA 94019 - USA

• Tipo de documento: Artigo de Revisão
• Fonte: Experimental Biology and Medicine; v. 246, n. 12, SI, p. 1458-1472, JUN 2021.
• Citações Web of Science: 0

Resumo

The pathophysiology of sickle cell anemia, a hereditary hemoglobinopathy, has fascinated clinicians and scientists alike since its description over 100 years ago. A single gene mutation in the HBB gene results in the production of abnormal hemoglobin (Hb) S, whose polymerization when deoxygenated alters the physiochemical properties of red blood cells, in turn triggering pan-cellular activation and pathological mechanisms that include hemolysis, vaso-occlusion, and ischemia-reperfusion to result in the varied and severe complications of the disease. Now widely regarded as an inflammatory disease, in recent years attention has included the role of leukocytes in vaso-occlusive processes in view of the part that these cells play in innate immune processes, their inherent ability to adhere to the endothelium when activated, and their sheer physical and potentially obstructive size. Here, we consider the role of sickle red blood cell populations in elucidating the importance of adhesion vis-a-vis polymerization in vaso-occlusion, review the direct adhesion of sickle red cells to the endothelium in vaso-occlusive processes, and discuss how red cell- and leukocyte-centered mechanisms are not mutually exclusive. Given the initial clinical success of crizanlizumab, a specific anti-P selectin therapy, we suggest that it is appropriate to take a holistic approach to understanding and exploring the complexity of vaso-occlusive mechanisms and the adhesive roles of the varied cell types, including endothelial cells, platelets, leukocytes, and red blood cells. (AU)

• Processo FAPESP: 14/00984-3 - Doenças dos glóbulos vermelhos: fisiopatologia e novas abordagens terapêuticas
• Beneficiário: Fernando Ferreira Costa
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 18/08010-9 - Caracterização dos efeitos inflamatórios de processos hemolíticos intravasculares, in vitro e in vivo
• Beneficiário: Nicola Amanda Conran Zorzetto
• Modalidade de apoio: Auxílio à Pesquisa - Regular